The Food and Drug Administration has announced that the risk of heart disease and other heart-related conditions may increase if an individual is smoking cigarettes; preventing and quitting such habit will most probably lessen the risk. But the agency noted that if you are using Chantix, a drug that helps smokers to quit the routine, it could be linked to a small risk of having heart-related diseases.
For the evaluation, experts looked at data from a population of 700 patients who have been identified with heart disease. This group of people was divided into two; one was assigned to take Chantix for a period of 12 weeks and the other took only placebo. The findings showed that those who took Chantix were more likely to go through heart-related conditions after one year compared to those who had placebo. On a lighter note, heart attack risks are significantly small – 3 patients out of 350 who had placebo while 7 who had Chantix.
Moreover, the FDA recommends patients who took the drug to visit their doctors. This is to verify if the patient has a worsening or new indication of heart disease, including chest pain, pain when walking or difficulty in breathing.
In addition, Chantrix was also notified to be connected in the increased risk of suicidal behaviors, not just heart diseases.
No comments:
Post a Comment